Plasma metabonomic study on the effect of <em>Para</em>‑hydroxybenzaldehyde intervention in a rat model of transient focal cerebral ischemia

Yu,Xinglin; Luo,Yuan; Yang,Liping; Duan,Xiaohua

doi:10.3892/mmr.2023.13111

Plasma metabonomic study on the effect of Para‑hydroxybenzaldehyde intervention in a rat model of transient focal cerebral ischemia

Authors:
- Xinglin Yu
- Yuan Luo
- Liping Yang
- Xiaohua Duan
View Affiliations

Affiliations: Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, P.R. China
Published online on: October 6, 2023 https://doi.org/10.3892/mmr.2023.13111
Article Number: 224
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastrodia elata Blume has been widely used to treat various central and peripheral nerve diseases, and Para‑hydroxybenzaldehyde (PHBA) is one of the indicated components suggested to provide a neuroprotective effect. In our previous, it was shown that PHBA protected mitochondria against cerebral ischemia‑reperfusion (I/R) injury in rats. In the present study, how PHBA regulated the metabolic mechanism in blood following cerebral I/R was assessed to identify an effective therapeutic target for the prevention and treatment of ischemic stroke (IS). First, a rat model of cerebral ischemia‑reperfusion injury was established via middle cerebral artery occlusion/reperfusion (MCAO/R). The therapeutic effect of PHBA on brain I/R was evaluated by assessing the neurological function score, triphenyl tetrazolium chloride, hematoxylin and eosin, and Nissl staining. Next, a non‑targeted metabolomic based on high‑performance liquid chromatography quadrupole time‑of‑flight mass spectrometry was established to identify differential metabolites. Finally, a targeted metabolic spectrum was analyzed and the potential therapeutic targets were verified by Western blotting. The results showed that the neurological function score, cerebral infarction area, hippocampal morphology, and the number of neurons in the PHBA group were significantly improved compared with the model group. Metabonomic analysis showed that 13 different metabolites were identified between the model and PHBA group, which may be involved in the ‘tricarboxylic acid cycle’, ‘glutathione metabolism’, and ‘mutual transformation of pentose and glucuronates’, amongst others. Among these, the levels of the most significant differential metabolite, dGMP, decreased significantly following PHBA treatment. Western blotting was used to verify the expression of membrane‑associated guanosine kinase PSD‑95 and the subunit of glutamate AMPA receptor GluA1, which significantly increased after PHBA treatment. In addition, it was also found that PHBA increased the expression of the light chain‑3 protein and autophagy effector protein 1, whilst the expression of sequestosome‑1 decreased, indicating that PHBA promoted autophagy. Similarly, in TUNEL staining and detection of apoptosis‑related proteins, it was found that MCAO/R upregulated the expression of Bax and cleaved‑caspase‑3 whilst downregulating the expression of Bcl‑2 and increasing the apoptosis of hippocampal neurons; PHBA reversed this situation. These results suggest that cerebral I/R causes postsynaptic dysfunction by disrupting the interaction between PSD‑95 and AMPARs, and the inhibition of the autophagy system eventually leads to the apoptosis of hippocampal neurons.

View Figures

View References

1	No authors listed. Corrigendum to: World stroke organization (WSO): Global stroke fact sheet 2022. Int J Stroke. 17:4782022. View Article : Google Scholar : PubMed/NCBI
2	Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, Li CY and Li CJ: Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 46:1650–1667. 2018. View Article : Google Scholar : PubMed/NCBI
3	Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN and Yang Y: Free radical damage in ischemia-reperfusion injury: An obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev. 2018:38049792018. View Article : Google Scholar : PubMed/NCBI
4	Messmer SJ, Salmeron KE, Frank JA, McLouth CJ, Lukins DE, Hammond TC, Lin AL, Fraser JF and Pennypacker KR: Extended middle cerebral artery occlusion (MCAO) model to mirror stroke patients undergoing thrombectomy. Transl Stroke Res. 13:604–615. 2022. View Article : Google Scholar : PubMed/NCBI
5	Ha JH, Lee DU, Lee JT, Kim JS, Yong CS, Kim JA, Ha JS and Huh K: 4-Hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain. J Ethnopharmacol. 73:329–333. 2000. View Article : Google Scholar : PubMed/NCBI
6	He F, Duan X, Dai R, Wang W, Yang C and Lin Q: Protective effects of ethyl acetate extraction from Gastrodia elata blume on blood-brain barrier in focal cerebral ischemia reperfusion. Afr J Tradit Complement Altern Med. 13:199–209. 2016. View Article : Google Scholar : PubMed/NCBI
7	Zhu YP, Li X, Du Y, Zhang L, Ran L and Zhou NN: Protective effect and mechanism of p-hydroxybenzaldehyde on blood-brain barrier. Zhongguo Zhong Yao Za Zhi. 43:1021–1027. 2018.(In Chinese). PubMed/NCBI
8	Kim HJ, Hwang IK and Won MH: Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia. Brain Res. 1181:130–141. 2007. View Article : Google Scholar : PubMed/NCBI
9	Feng J, Yang JG, Yang QY, Xu Y and He F: Pharmacokinetics of metabolites of p-hydroxybenzaldehyde in rats. China pharmaceuticals. 29:9–12. 2020.(In Chinese).
10	Xiao T, Yang L, Chen P and Duan X: Para-hydroxybenzaldehyde against transient focal cerebral ischemia in rats via mitochondrial preservation. Exp Ther Med. 24:7162022. View Article : Google Scholar : PubMed/NCBI
11	Luo Y, Chen P, Yang L and Duan X: Metabolomic analysis and pharmacological validation of the cerebral protective effect of 3,4-dihydroxybenzaldehyde on cerebral ischemia-reperfusion injury. Mol Med Rep. 27:92023. View Article : Google Scholar : PubMed/NCBI
12	Ramana P, Adams E, Augustijns P and Van Schepdael A: Metabonomics and drug development. Methods Mol Biol. 1277:195–207. 2015. View Article : Google Scholar : PubMed/NCBI
13	Wu Z, Qian S, Zhao L, Zhang Z, Song C, Chen L, Gao H and Zhu W: Metabolomics-based study of the potential interventional effects of Xiao-Xu-Ming Decoction on cerebral ischemia/reperfusion rats. J Ethnopharmacol. 295:1153792022. View Article : Google Scholar : PubMed/NCBI
14	Wang D, Wang Q, Chen R, Yang S, Li Z and Feng Y: Exploring the effects of Gastrodia elata Blume on the treatment of cerebral ischemia-reperfusion injury using UPLC-Q/TOF-MS-based plasma metabolomics. Food Funct. 10:7204–7215. 2019. View Article : Google Scholar : PubMed/NCBI
15	Zhang P, Huang Z, Yan HQ, Su LL, Gui YK, Lv HX, Zhu B and Li T: Improvement of the suture-occluded method in rat models of focal cerebral ischemia-reperfusion. Exp Ther Med. 7:657–662. 2014. View Article : Google Scholar : PubMed/NCBI
16	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the care and use of laboratory animals. 8th edition. Washington (DC): National Academies Press (US); 2011
17	Liu J, Yang L, Niu Y, Su C, Wang Y, Ren R, Chen J and Ma X: Potential therapeutic effects of Mi-Jian-Chang-Pu Decoction on neurochemical and metabolic changes of cerebral ischemia-reperfusion injury in rats. Oxid Med Cell Longev. 2022:73195632022.PubMed/NCBI
18	Li H, Peng D, Zhang SJ, Zhang Y, Wang Q and Guan L: Buyang Huanwu Decoction promotes neurogenesis via sirtuin 1/autophagy pathway in a cerebral ischemia model. Mol Med Rep. 24:7912021. View Article : Google Scholar : PubMed/NCBI
19	Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, Kanazawa M, VanderGheynst J, Fiehn O and Arita M: MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 12:523–526. 2015. View Article : Google Scholar : PubMed/NCBI
20	Heinemann J: Cluster analysis of untargeted metabolomic experiments. Methods Mol Biol. 1859:275–285. 2019. View Article : Google Scholar : PubMed/NCBI
21	Liu S, Xie X, Lei H, Zou B and Xie L: Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 25:1679–1693. 2019. View Article : Google Scholar : PubMed/NCBI
22	Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, et al: The genetic landscape of renal complications in type 1 diabetes. J Am Soc Nephrol. 28:557–574. 2017. View Article : Google Scholar : PubMed/NCBI
23	Kumar V, Spangenberg O and Konrad M: Cloning of the guanylate kinase homologues AGK-1 and AGK-2 from Arabidopsis thaliana and characterization of AGK-1. Eur J Biochem. 267:606–615. 2000. View Article : Google Scholar : PubMed/NCBI
24	Yan BC, Park JH, Ahn JH, Lee JC, Won MH and Kang IJ: Postsynaptic density protein (PSD)-95 expression is markedly decreased in the hippocampal CA1 region after experimental ischemia-reperfusion injury. J Neurol Sci. 330:111–116. 2013. View Article : Google Scholar : PubMed/NCBI
25	Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E and Guidotti A: The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA. 103:1587–1592. 2006. View Article : Google Scholar : PubMed/NCBI
26	Kumaran D, Udayabanu M, Nair RU, R A and Katyal A: Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia. Behav Brain Res. 192:178–184. 2008. View Article : Google Scholar : PubMed/NCBI
27	Geenen S, Guallar-Hoyas C, Michopoulos F, Kenna JG, Kolaja KL, Westerhoff HV, Thomas P and Wilson ID: HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. J Pharm Biomed Anal. 56:655–663. 2011. View Article : Google Scholar : PubMed/NCBI
28	Jiang Z, Sun J, Liang Q, Cai Y, Li S, Huang Y, Wang Y and Luo G: A metabonomic approach applied to predict patients with cerebral infarction. Talanta. 84:298–304. 2011. View Article : Google Scholar : PubMed/NCBI
29	Deery DJ and Taylor KW: Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. Biochem J. 134:557–563. 1973. View Article : Google Scholar : PubMed/NCBI
30	Jiang T, Jiao J, Shang J, Bi L, Wang H, Zhang C, Wu H, Cui Y, Wang P and Liu X: The differences of metabolites in different parts of the brain induced by shuxuetong injection against cerebral ischemia-reperfusion and its corresponding mechanism. Evid Based Complement Alternat Med. 2022:94650952022. View Article : Google Scholar : PubMed/NCBI
31	Du C, Cao S, Shi X, Nie X, Zheng J, Deng Y, Ruan L, Peng D and Sun M: Genetic and biochemical characterization of a gene operon for trans-aconitic acid, a novel nematicide from bacillus thuringiensis. J Biol Chem. 292:3517–3530. 2017. View Article : Google Scholar : PubMed/NCBI
32	Zhang C, Ling CL, Pang L, Wang Q, Liu JX, Wang BS, Liang JM, Guo YZ, Qin J and Wang JX: Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles. Theranostics. 7:3260–3275. 2017. View Article : Google Scholar : PubMed/NCBI
33	Chen XL, Su SL, Liu R, Qian DW, Chen LL, Qiu LP and Duan JA: Chemical constituents and pharmacological action of bile acids from animal: A review. Zhongguo Zhong Yao Za Zhi. 46:4898–4906. 2021.(In Chinese). PubMed/NCBI
34	Li C, Wang X, Yan J, Cheng F, Ma X, Chen C, Wang W and Wang Q: Cholic acid protects in vitro neurovascular units against oxygen and glucose deprivation-induced injury through the BDNF-TrkB signaling pathway. Oxid Med Cell Longev. 2020:12016242020. View Article : Google Scholar : PubMed/NCBI
35	Quinn M, McMillin M, Galindo C, Frampton G, Pae HY and DeMorrow S: Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig Liver Dis. 46:527–534. 2014. View Article : Google Scholar : PubMed/NCBI
36	Menni C, Graham D, Kastenmüller G, Alharbi NH, Alsanosi SM, McBride M, Mangino M, Titcombe P, Shin SY, Psatha M, et al: Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension. 66:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
37	Sun D, Tiedt S, Yu B, Jian X, Gottesman RF, Mosley TH, Boerwinkle E, Dichgans M and Fornage M: A prospective study of serum metabolites and risk of ischemic stroke. Neurology. 92:e1890–e1898. 2019. View Article : Google Scholar : PubMed/NCBI
38	Dong Y and Li HF: Research status of inherited disorders of metal metabolism in nervous system and the challenges faced. Chin J Pract Intern Med. 42:278–282. 2022.
39	Mendez NV, Wharton JA, Leclerc JL, Blackburn SL, Douglas-Escobar MV, Weiss MD, Seubert CN and Doré S: Clinical implications of bilirubin-associated neuroprotection and neurotoxicity. Int J Clin Anesthesiol. 1:10132013.PubMed/NCBI
40	Amin SB, Smith T and Timler G: Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders. Pediatr Res. 85:191–197. 2019. View Article : Google Scholar : PubMed/NCBI
41	Kurzepa J, Bielewicz J, Stelmasiak Z and Bartosik-Psujek H: Serum bilirubin and uric acid levels as the bad prognostic factors in the ischemic stroke. Int J Neurosci. 119:2243–2249. 2009. View Article : Google Scholar : PubMed/NCBI
42	Siebert H, Engelke S, Maruschak B and Brück W: Concentration-dependent effects of the esterase inhibitor BNPP on macrophage migration and myelin phagocytosis. Brain Res. 916:159–164. 2001. View Article : Google Scholar : PubMed/NCBI
43	Batirel HF, Aktan S, Aykut C, Yeğen BC and Coşkun T: The effect of aqueous garlic extract on the levels of arachidonic acid metabolites (leukotriene C4 and prostaglandin E2) in rat forebrain after ischemia-reperfusion injury. Prostaglandins Leukot Essent Fatty Acids. 54:289–292. 1996. View Article : Google Scholar : PubMed/NCBI
44	Rao AM, Hatcher JF, Kindy MS and Dempsey RJ: Arachidonic acid and leukotriene C4: Role in transient cerebral ischemia of gerbils. Neurochem Res. 24:1225–1232. 1999. View Article : Google Scholar : PubMed/NCBI
45	Nguyen BT and Sadée W: Compartmentation of guanine nucleotide precursors for DNA synthesis. Biochem J. 234:263–269. 1986. View Article : Google Scholar : PubMed/NCBI
46	Kim E and Sheng M: PDZ domain proteins of synapses. Nat Rev Neurosci. 5:771–781. 2004. View Article : Google Scholar : PubMed/NCBI
47	Buonarati OR, Hammes EA, Watson JF, Greger IH and Hell JW: Mechanisms of postsynaptic localization of AMPA-type glutamate receptors and their regulation during long-term potentiation. Sci Signal. 12:eaar68892019. View Article : Google Scholar : PubMed/NCBI
48	Mardones MD, Jorquera PV, Herrera-Soto A, Ampuero E, Bustos FJ, van Zundert B and Varela-Nallar L: PSD95 regulates morphological development of adult-born granule neurons in the mouse hippocampus. J Chem Neuroanat. 98:117–123. 2019. View Article : Google Scholar : PubMed/NCBI
49	Poels J, Spasić MR, Callaerts P and Norga KK: An appetite for destruction: From self-eating to cell cannibalism as a neuronal survival strategy. Autophagy. 8:1401–1403. 2012. View Article : Google Scholar : PubMed/NCBI
50	Overhoff M, De Bruyckere E and Kononenko NL: Mechanisms of neuronal survival safeguarded by endocytosis and autophagy. J Neurochem. 157:263–296. 2021. View Article : Google Scholar : PubMed/NCBI
51	Lou G, Palikaras K, Lautrup S, Scheibye-Knudsen M, Tavernarakis N and Fang EF: Mitophagy and neuroprotection. Trends Mol Med. 26:8–20. 2020. View Article : Google Scholar : PubMed/NCBI
52	Jiang T, Yu JT, Zhu XC, Zhang QQ, Tan MS, Cao L, Wang HF, Shi JQ, Gao L, Qin H, et al: Ischemic preconditioning provides neuroprotection by induction of AMP-activated protein kinase-dependent autophagy in a rat model of ischemic stroke. Mol Neurobiol. 51:220–229. 2015. View Article : Google Scholar : PubMed/NCBI
53	Dai SH, Chen T, Li X, Yue KY, Luo P, Yang LK, Zhu J, Wang YH, Fei Z and Jiang XF: Sirt3 confers protection against neuronal ischemia by inducing autophagy: Involvement of the AMPK-mTOR pathway. Free Radic Biol Med. 108:345–353. 2017. View Article : Google Scholar : PubMed/NCBI
54	Tran S, Fairlie WD and Lee EF: BECLIN1: Protein structure, function and regulation. Cells. 10:15222021. View Article : Google Scholar : PubMed/NCBI
55	Lamark T, Svenning S and Johansen T: Regulation of selective autophagy: The p62/SQSTM1 paradigm. Essays Biochem. 61:609–624. 2017. View Article : Google Scholar : PubMed/NCBI
56	Ritzel RM, Li Y, He J, Khan N, Doran SJ, Faden AI and Wu J: Sustained neuronal and microglial alterations are associated with diverse neurobehavioral dysfunction long after experimental brain injury. Neurobiol Dis. 136:1047132020. View Article : Google Scholar : PubMed/NCBI
57	Li Z, Xiao G, Wang H, He S and Zhu Y: A preparation of Ginkgo biloba L. leaves extract inhibits the apoptosis of hippocampal neurons in post-stroke mice via regulating the expression of Bax/Bcl-2 and caspase-3. J Ethnopharmacol. 280:1144812021. View Article : Google Scholar : PubMed/NCBI